Commission Implementing Decision (EU) 2025/2344 of 19 November 2025 repealing Implementing Decision (EU) 2024/2930 postponing the expiry date of the approval of dazomet for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council